Showing results (31-40 of 177) with videos related to
Sort By:
Pageof 18
Japanese Journal of Cancer Research : Gann|March 1, 1989
Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytesY Kaneko, H F Oettgen, Y Obata, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferonF X Real, H F Oettgen, S E KrownProceedings of the National Academy of Sciences of the United States of America|October 1, 1974
Enhancement of tumor growth by graft-versus-host reactionS Okubo, H F Oettgen, S S Caiazza, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1984
T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell culturesA Knuth, B Danowski, H F Oettgen, et al.Cancer Research|February 1, 1983
Characterization of interleukin 2-dependent cytotoxic T-cell clones: specificity, cell surface phenotype, and susceptibility to blocking by Lyt antiseraM A Palladino, Y Obata, E Stockert, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1976
Macrophage requirements of CR- and CR+ B lymphocytes for antibody production in vitroM K Hoffmann, U Hämmerling, M Simon, et al.The Journal of Experimental Medicine|December 1, 1977
B-cell activation by lipopolysaccharide. Distinct pathways for induction of mitosis and antibody productionM K Hoffmann, C Galanos, S Koenig, et al.Journal of the National Cancer Institute|February 1, 1975
Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity testH Shiku, M A Bean, L J Old, et al.Journal of Surgical Oncology|September 1, 1985
Malignant melanoma appearing in a post-mastectomy lymphedematous arm: a novel association of double primary tumorsA H Bartal, C M PinskyCellular Immunology|July 1, 1984
Characterization of interleukin 2 (IL-2)-dependent cytotoxic T-cell clones. V. Transfer of resistance to allografts and tumor grafts requires exogenous IL-2M A Palladino, K Welte, A M Carroll, et al.Pageof 18